Physicians' Academy for Cardiovascular Education

ARNI as first-line therapy in de novo HFrEF patients after ADHF event

3' education - June 3, 2019

Educational information

This video was recorded at the ESC Heart Failure in Athens, Greece, on May 27, 2019 and is a reproduction of his presentation during the Rapid Fire 4 - Chronic heart failure - Pharmacology session.


Michele Senni, MD, is cardiologist at the Hospital Papa Giovanni XXIII, Bergamo, Italy.


This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenters and do not necessarily reflect the views of PACE-cme.

Read our summary of the subanalysis of the TRANSITION trial

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: